Cargando…
Scope of nanotechnology in ovarian cancer therapeutics
This review describes the use of polymer micelle nanotechnology based chemotherapies for ovarian cancer. While various chemotherapeutic agents can be utilized to improve the survival rate of patients with ovarian cancer, their distribution throughout the entire body results in high normal organ toxi...
Autores principales: | Yallapu, Murali M, Jaggi, Meena, Chauhan, Subhash C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924337/ https://www.ncbi.nlm.nih.gov/pubmed/20691083 http://dx.doi.org/10.1186/1757-2215-3-19 |
Ejemplares similares
-
miR-205: A Potential Biomedicine for Cancer Therapy
por: Chauhan, Neeraj, et al.
Publicado: (2020) -
Biomolecule-functionalized nanoformulations for prostate cancer theranostics
por: Pranav, et al.
Publicado: (2022) -
Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
por: Yallapu, Murali M, et al.
Publicado: (2010) -
Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics
por: Kashyap, Vivek K., et al.
Publicado: (2022) -
miRNA-205: a future therapeutic molecule for liver diseases
por: Cabrera, Marco, et al.
Publicado: (2023)